Depo-Medrate ad us. vet.
Depo-Medrate ad us. vet.
Authorised
- Methylprednisolone acetate
Product identification
Medicine name:
Depo-Medrate ad us. vet.
Active substance:
- Methylprednisolone acetate
Target species:
-
Cat
-
Dog
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Methylprednisolone acetate40.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cat
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH02AB04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- Available only in German
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Pfizer Manufacturing Belgium
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 6177359.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 2/09/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 2/09/2024
How useful was this page?:
